We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Etsy
ETSY
$6.83B
| $34M | 0.08% |
402,071
+51,434
| +15% | +$4.85M |
|
277
Allstate
ALL
$64.2B
| $34M | 0.08% |
311,697
-118,627
| -28% | -$13.5M |
|
278
Penumbra
PEN
$12.5B
| $33.2M | 0.08% |
96,535
-16,855
| -15% | -$5.18M |
|
279
Amylyx Pharmaceuticals
AMLX
$3.75B
| $33M | 0.08% |
1,529,000
-317,117
| -17% | -$8.56M |
|
280
Dell
DELL
$340B
| $32.9M | 0.08% |
607,294
-37,202
| -6% | -$1.71M |
|
281
Linde
LIN
$214B
| $32.7M | 0.08% |
85,820
-62,936
| -42% | -$23M |
|
282
Vulcan Materials
VMC
$32.7B
| $32.7M | 0.08% |
144,950
-9,065
| -6% | -$1.74M |
|
|
P
283
Everpure Inc
P
$31.3B
| $32.6M | 0.08% |
886,129
-116,358
| -12% | -$3.3M |
|
284
Guardant Health
GH
$21.1B
| $32.5M | 0.08% |
909,000
+300,000
| +49% | +$8.62M |
|
285
Advanced Drainage Systems
WMS
$9.64B
| $32.5M | 0.08% |
285,987
+72,298
| +34% | +$6.82M |
|
286
Power Integrations
POWI
$2.92B
| $32.5M | 0.08% |
343,639
-17,560
| -5% | -$1.47M |
|
287
Gartner
IT
$12.4B
| $32.4M | 0.08% |
92,454
-1,987
| -2% | -$647K |
|
288
Rockwell Automation
ROK
$47.6B
| $32.1M | 0.08% |
97,355
+15,101
| +18% | +$4.36M |
|
289
Custom Truck One Source
CTOS
$2.07B
| $31.9M | 0.08% |
4,735,616
+896
| +0% | +$5.9K |
|
290
Stryker
SYK
$108B
| $31.7M | 0.08% |
103,799
+6,551
| +7% | +$1.89M |
|
291
Copart
CPRT
$29.4B
| $31.4M | 0.08% |
689,382
+25,170
| +4% | +$1.04M |
|
292
Analog Devices
ADI
$175B
| $31.4M | 0.08% |
161,253
-2,244
| -1% | -$416K |
|
293
Denali Therapeutics
DNLI
$3.37B
| $31.4M | 0.08% |
1,063,500
| – | – |
|
|
ALTR
294
DELISTED
Altair Engineering Inc
ALTR
| $31M | 0.08% |
408,871
+81,450
| +25% | +$5.82M |
|
295
Berkshire Hathaway Class B
BRK.B
$1.1T
| $30.9M | 0.08% |
90,738
-6,828
| -7% | -$2.23M |
|
|
SMAR
296
DELISTED
Smartsheet Inc.
SMAR
| $30.7M | 0.08% |
803,680
+3,680
| +0.5% | +$159K |
|
297
Verisk Analytics
VRSK
$22.9B
| $30.6M | 0.08% |
135,178
+129,718
| +2,376% | +$27.2M |
|
298
StoneCo
STNE
$2.33B
| $30.5M | 0.08% |
2,392,024
+760,447
| +47% | +$9.48M |
|
299
SBA Communications
SBAC
$19.7B
| $30.2M | 0.07% |
130,109
+1,031
| +0.8% | +$247K |
|
300
Telus
TU
$14.3B
| $30.1M | 0.07% |
1,548,996
-4,829
| -0.3% | -$97.2K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.